Table I.
CC | ||||
---|---|---|---|---|
Characteristic | Normal | SCC | AC | ASC |
Participants, n (%) | 390 | 235 (90.7%) | 23 (8.9%) | 1 (0.4%) |
Age, mean ± standard deviation | 35.8±9.7 | 50.7±11.3 | 50.8±11.0 | 38 |
Age, n | ||||
<40 | 258 | 32 | 5 | 1 |
40–50 | 94 | 102 | 7 | N/A |
>50 | 38 | 101 | 11 | N/A |
FIGO stage, n (%) | N/A | 235 (90.7%) | 23 (8.9%) | 1 (0.4%) |
I | N/A | 119 (45.9%) | 16 (6.2%) | N/A |
II | N/A | 90 (34.7%) | 6 (2.3%) | N/A |
III/IV | N/A | 26 (10.1%) | 1 (0.4%) | 1 (0.4%) |
CC, cervical cancer; SCC, squamous cell carcinoma; AC, cervical adenocarcinoma; ASC, adenosquamous cervical carcinoma; FIGO, The International Federation of Gynecology and Obstetrics.